Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Pharmacological Reviews
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Pharmacological Reviews

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit Pharm Rev on Facebook
  • Follow Pharm Rev on Twitter
  • Follow ASPET on LinkedIn
Research Article

DRUGS AND PORPHYRIN METABOLISM

M. WEATHERALL
Pharmacological Reviews June 1954, 6 (2) 133-158;
M. WEATHERALL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

One or two ways in which porphyrin metabolism might be disturbed, such as disturbances of the formation and breakdown of myoglobin or of the cytochromes, have not been mentioned, because there is little or no evidence whether drugs affect them. Most of the known disturbances of porphyrin metabolism involve either haemopoiesis or liver function. Lead poisoning is clearly in the first category, poisoning by Sedormid and other substances containing allyl groups in the second. The mild porphyrinuria produced by aromatic amines and nitro-compounds may be due to abnormal haemoglobin breakdown, but seems more likely to be comparable to the effect of lead. The dyshaemopoietic porphyrinurias can be conceived simply as due to blockage at one or more stages of the normal synthesis of iron-protoporphyrin, so that intermediaries or products of diverted metabolism such as coproporphyrin appear in excess. Details about the stage of blockage have still to be worked out. The porphyrinurias associated with changes in the liver are less comprehensible. They may involve abnormal formation or destruction of iron-porphyrin compounds which are synthesized by a mechanism different from the haemopoietic one, and so susceptible to damage by different agents; or they may arise through some as yet undetermined influence of the liver on haemopoiesis, for example, in synthesizing, excreting or failing to excrete some essential intermediary metabolite. The particular porphyrins which appear in the urine are not diagnostic of the site of the disturbance; porphobilinogen and uroporphyrin appear after Sedormid and after the combination of phenylhydrazine, lead and light and coproporphyrin appears both when the liver is diseased, and after interference with haemopoiesis by lead. The isomeric type is also not diagnostic. There is a connexion between coproporphyrin I excretion and increased haemopoiesis and coproporphyrin III excretion and obstructed haemopoiesis, but with the uroporphyrinurias and in liver disease there is a notable variability in the isomer type in any particular condition. The most promising developments now appear to be in the study of isolated tissue systems or homogenates, in the further investigation of precursors and the conditions under which they form free porphyrins, and in examining in more detail the actions of drugs on the tissue porphyrins as well as on the porphyrins excreted by experimental animals.

PharmRev articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Pharmacological Reviews
Vol. 6, Issue 2
1 Jun 1954
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Pharmacological Reviews article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
DRUGS AND PORPHYRIN METABOLISM
(Your Name) has forwarded a page to you from Pharmacological Reviews
(Your Name) thought you would be interested in this article in Pharmacological Reviews.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research Article

DRUGS AND PORPHYRIN METABOLISM

M. WEATHERALL
Pharmacological Reviews June 1, 1954, 6 (2) 133-158;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research Article

DRUGS AND PORPHYRIN METABOLISM

M. WEATHERALL
Pharmacological Reviews June 1, 1954, 6 (2) 133-158;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Pharmacological Reviews
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacology Research & Perspectives
ISSN 1521-0081 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics